Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

0 Calificaciones
0
Episodio
81 of 193
Duración
38min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Rerun:

“I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug.

The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai Ovenberg. Background research was done by Sigurd Brekke with input from portfolio manager Gemma Game.

• Watch the episode on YouTube: Norges Bank Investment Management - YouTube • Want to learn more about the fund? The fund | Norges Bank Investment Management (nbim.no) • Follow Nicolai Tangen on LinkedIn: Nicolai Tangen | LinkedIn • Follow NBIM on LinkedIn: Norges Bank Investment Management: Administrator for bedriftsside | LinkedIn • Follow NBIM on Instagram: Explore Norges Bank Investment Management on Instagram

Hosted on Acast. See acast.com/privacy for more information.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

Otros podcasts que te pueden gustar...